<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Bayer Says It Will Stop Sale of Endosulfan by 2010</title>
	<atom:link href="http://www.beyondpesticides.org/dailynewsblog/?feed=rss2&#038;p=2218" rel="self" type="application/rss+xml" />
	<link>http://www.beyondpesticides.org/dailynewsblog/?p=2218</link>
	<description>News on pesticide science, policy and activism</description>
	<lastBuildDate>Wed, 15 May 2013 15:03:25 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
	<item>
		<title>By: Satyabroto Banerji</title>
		<link>http://www.beyondpesticides.org/dailynewsblog/?p=2218#comment-84519</link>
		<dc:creator>Satyabroto Banerji</dc:creator>
		<pubDate>Tue, 11 Aug 2009 14:01:42 +0000</pubDate>
		<guid isPermaLink="false">http://www.beyondpesticides.org/dailynewsblog/?p=2218#comment-84519</guid>
		<description><![CDATA[Bayer has never been active with Endosulfan. This economical and versatile IPM and IRM tool was first discovered by a company that Bayer has taken over. Bayer stands to gain most from bans on Endosulfan because no farmer would pay the premium for a substitute application of a patented neonicotinoid. European pesticide companies are notorious for belittling their own inventions once they lose monopoly rights. The toxicology profile of Endosulfan is not remarkable compared to competitive active ingredients.]]></description>
		<content:encoded><![CDATA[<p>Bayer has never been active with Endosulfan. This economical and versatile IPM and IRM tool was first discovered by a company that Bayer has taken over. Bayer stands to gain most from bans on Endosulfan because no farmer would pay the premium for a substitute application of a patented neonicotinoid. European pesticide companies are notorious for belittling their own inventions once they lose monopoly rights. The toxicology profile of Endosulfan is not remarkable compared to competitive active ingredients.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
